Rivastigmine for Dementia Associated with Parkinson's Disease

20041,208 citationsJournal Articlebronze Open Access

Authors

Murat Emre · Istanbul University

Dag Aarsland · University of Bergen

Alberto Albanese · Fondazione IRCCS Istituto Neurologico Carlo Besta

E. Jane Byrne · University of Manchester

Günther Deuschl

Peter Paul De Deyn · University of Antwerp

Franck Durif · Centre Hospitalier Universitaire de Clermont-Ferrand

Abstract

In this placebo-controlled study, rivastigmine was associated with moderate improvements in dementia associated with Parkinson's disease but also with higher rates of nausea, vomiting, and tremor.

Topics & Keywords

Parkinson's Disease Mechanisms and Treatments Cholinesterase and Neurodegenerative Diseases Ginkgo biloba and Cashew Applications

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 351, Issue 24, pp. 2509-2518

DOI: 10.1056/nejmoa041470

Field-Weighted Citation Impact: 57.13